• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

pH sensitive liposomes provide an efficient means of sensitizing target cells to class I restricted CTL recognition of a soluble protein.

作者信息

Reddy R, Zhou F, Huang L, Carbone F, Bevan M, Rouse B T

机构信息

Department of Microbiology, University of Tennessee, Knoxville 37996.

出版信息

J Immunol Methods. 1991 Aug 9;141(2):157-63. doi: 10.1016/0022-1759(91)90142-3.

DOI:10.1016/0022-1759(91)90142-3
PMID:1880423
Abstract

Exogenous antigens are normally endocytosed and enter the class II pathway of processing and presentation. It had been shown earlier that soluble antigen could be introduced into the class I pathway of processing and presentation by osmotic loading. In this report, we have demonstrated that OVA containing liposomes that destabilize on exposure to low pH, referred to as pH sensitive liposomes, could sensitize target cells to lysis by class I MHC-restricted OVA-specific CTL. However, OVA-containing pH insensitive liposomes, native OVA, or OVA subjected to the same protocol as was used to make the liposomes, failed to sensitize targets to OVA-specific CTL lysis. The pH sensitive liposomal approach was less toxic and more efficient (about 20-fold) in delivering than the osmotic loading approach. The pH liposome approach may prove valuable to study CTL recognition characteristics of less available proteins such as viral proteins.

摘要

相似文献

1
pH sensitive liposomes provide an efficient means of sensitizing target cells to class I restricted CTL recognition of a soluble protein.
J Immunol Methods. 1991 Aug 9;141(2):157-63. doi: 10.1016/0022-1759(91)90142-3.
2
Electroporation and commercial liposomes efficiently deliver soluble protein into the MHC class I presentation pathway. Priming in vitro and in vivo for class I-restricted recognition of soluble antigen.电穿孔和商用脂质体可有效地将可溶性蛋白质递送至MHC I类呈递途径。在体外和体内进行致敏以实现对可溶性抗原的I类限制性识别。
J Immunol Methods. 1993 Mar 15;160(1):49-57. doi: 10.1016/0022-1759(93)90007-t.
3
Class I restricted CTL recognition of a soluble protein delivered by liposomes containing lipophilic polylysines.
J Immunol Methods. 1992 Aug 10;152(2):237-43. doi: 10.1016/0022-1759(92)90145-j.
4
An improved method of loading pH-sensitive liposomes with soluble proteins for class I restricted antigen presentation.
J Immunol Methods. 1991 Dec 15;145(1-2):143-52. doi: 10.1016/0022-1759(91)90320-f.
5
Fusogenic liposomes efficiently deliver exogenous antigen through the cytoplasm into the MHC class I processing pathway.融合脂质体可有效地将外源性抗原通过细胞质递送至MHC I类加工途径。
Eur J Immunol. 2000 Jun;30(6):1740-7. doi: 10.1002/1521-4141(200006)30:6<1740::AID-IMMU1740>3.0.CO;2-U.
6
Archaeosomes induce long-term CD8+ cytotoxic T cell response to entrapped soluble protein by the exogenous cytosolic pathway, in the absence of CD4+ T cell help.在缺乏CD4+ T细胞辅助的情况下,古脂质体通过外源性胞质途径诱导对包裹的可溶性蛋白产生长期的CD8+ 细胞毒性T细胞反应。
J Immunol. 2000 Nov 1;165(9):5177-85. doi: 10.4049/jimmunol.165.9.5177.
7
Liposome-mediated cytoplasmic delivery of proteins: an effective means of accessing the MHC class I-restricted antigen presentation pathway.脂质体介导的蛋白质胞质递送:进入MHC I类限制性抗原呈递途径的有效手段。
Immunomethods. 1994 Jun;4(3):229-35. doi: 10.1006/immu.1994.1025.
8
Characterization and kinetics of MHC class I-restricted presentation of a soluble antigen delivered by liposomes.脂质体递送的可溶性抗原的MHC I类限制性呈递的表征及动力学
Immunobiology. 1994 Feb;190(1-2):35-52. doi: 10.1016/S0171-2985(11)80282-2.
9
Cytosolic Delivery of Liposomal Vaccines by Means of the Concomitant Photosensitization of Phagosomes.通过吞噬体的伴随光敏化实现脂质体疫苗的胞质递送。
Mol Pharm. 2016 Feb 1;13(2):320-9. doi: 10.1021/acs.molpharmaceut.5b00394. Epub 2016 Jan 6.
10
Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo.体内I类分子限制的外源性细胞相关抗原的加工与提呈
J Exp Med. 1990 Feb 1;171(2):377-87. doi: 10.1084/jem.171.2.377.

引用本文的文献

1
Lipid-based nanosystems: the next generation of cancer immune therapy.基于脂质的纳米系统:下一代癌症免疫治疗。
J Hematol Oncol. 2024 Jul 19;17(1):53. doi: 10.1186/s13045-024-01574-1.
2
Molecular Perspective of Nanoparticle Mediated Therapeutic Targeting in Breast Cancer: An Odyssey of Endoplasmic Reticulum Unfolded Protein Response (UPR) and Beyond.纳米颗粒介导的乳腺癌治疗靶向的分子视角:内质网未折叠蛋白反应(UPR)及其他的探索之旅
Biomedicines. 2021 Jun 2;9(6):635. doi: 10.3390/biomedicines9060635.
3
Preparation of nanoliposomes containing HER2/neu (P5+435) peptide and evaluation of their immune responses and anti-tumoral effects as a prophylactic vaccine against breast cancer.
制备含有 HER2/neu (P5+435) 肽的纳米脂质体,并评估其免疫反应和抗肿瘤效果作为预防乳腺癌的疫苗。
PLoS One. 2020 Dec 10;15(12):e0243550. doi: 10.1371/journal.pone.0243550. eCollection 2020.
4
Liposome Formulations as Adjuvants for Vaccines.脂质体配方作为疫苗佐剂。
Curr Top Microbiol Immunol. 2021;433:1-28. doi: 10.1007/82_2020_227.
5
The Role of Nanovaccine in Cross-Presentation of Antigen-Presenting Cells for the Activation of CD8 T Cell Responses.纳米疫苗在抗原呈递细胞交叉呈递以激活CD8 T细胞应答中的作用
Pharmaceutics. 2019 Nov 15;11(11):612. doi: 10.3390/pharmaceutics11110612.
6
Functional biomimetic nanoparticles for drug delivery and theranostic applications in cancer treatment.用于癌症治疗中药物递送和诊疗应用的功能性仿生纳米颗粒。
Sci Technol Adv Mater. 2018 Oct 26;19(1):771-790. doi: 10.1080/14686996.2018.1528850. eCollection 2018.
7
Cyclophosphamide eradicates murine immunogenic tumor coding for a non-self-antigen and induces antitumor immunity.环磷酰胺消除编码非自身抗原的小鼠免疫原性肿瘤,并诱导抗肿瘤免疫。
Int J Immunopathol Pharmacol. 2018 Jan-Dec;32:2058738418796591. doi: 10.1177/2058738418796591.
8
The Multirole of Liposomes in Therapy and Prevention of Infectious Diseases.脂质体在传染病治疗和预防中的多效作用。
Front Immunol. 2018 Feb 5;9:155. doi: 10.3389/fimmu.2018.00155. eCollection 2018.
9
Surrogate in vitro activation of innate immunity synergizes with interleukin-7 to unleash rapid antigen-driven outgrowth of CD4+ and CD8+ human peripheral blood T-cells naturally recognizing MUC1, HER2/neu and other tumor-associated antigens.先天免疫的替代体外激活与白细胞介素-7协同作用,促使天然识别MUC1、HER2/neu和其他肿瘤相关抗原的CD4+和CD8+人外周血T细胞在抗原驱动下快速增殖。
Oncotarget. 2017 Feb 14;8(7):10785-10808. doi: 10.18632/oncotarget.13911.
10
Preparation and characterization of different liposomal formulations containing P5 HER2/neu-derived peptide and evaluation of their immunological responses and antitumor effects.含P5 HER2/neu衍生肽的不同脂质体制剂的制备与表征及其免疫反应和抗肿瘤作用的评估
Iran J Basic Med Sci. 2015 May;18(5):506-13.